310 related articles for article (PubMed ID: 21979946)
21. Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes.
Orloff MS; He X; Peterson C; Chen F; Chen JL; Mester JL; Eng C
Am J Hum Genet; 2013 Jan; 92(1):76-80. PubMed ID: 23246288
[TBL] [Abstract][Full Text] [Related]
22. Identification of a Cowden syndrome patient with a novel PTEN mutation and establishment of patient-derived induced pluripotent stem cells.
Obayashi F; Hamada A; Yamasaki S; Kanda T; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):69-78. PubMed ID: 34984555
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer.
Agrawal S; Eng C
Hum Mol Genet; 2006 Mar; 15(5):777-87. PubMed ID: 16436456
[TBL] [Abstract][Full Text] [Related]
24. Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
Fackenthal JD; Marsh DJ; Richardson AL; Cummings SA; Eng C; Robinson BG; Olopade OI
J Med Genet; 2001 Mar; 38(3):159-64. PubMed ID: 11238682
[TBL] [Abstract][Full Text] [Related]
25. Thyroid Follicular Cell-derived Carcinomas in a Background of Multiple Adenomatous Nodules Leading to a Diagnosis of
Liu A; Borges PM; Tay YS; Thompson LDR; Kong MX; Lai J
Anticancer Res; 2022 Mar; 42(3):1481-1485. PubMed ID: 35220242
[TBL] [Abstract][Full Text] [Related]
26. KLLN epigenotype-phenotype associations in Cowden syndrome.
Nizialek EA; Mester JL; Dhiman VK; Smiraglia DJ; Eng C
Eur J Hum Genet; 2015 Nov; 23(11):1538-43. PubMed ID: 25669429
[TBL] [Abstract][Full Text] [Related]
27. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.
Ngeow J; Eng C
Methods; 2015 May; 77-78():11-9. PubMed ID: 25461771
[TBL] [Abstract][Full Text] [Related]
28. Novel Germline
Lopez C; Abuel-Haija M; Pena L; Coppola D
Cancer Genomics Proteomics; 2018; 15(2):115-120. PubMed ID: 29496690
[TBL] [Abstract][Full Text] [Related]
29. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
[TBL] [Abstract][Full Text] [Related]
30. Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation.
Teresi RE; Zbuk KM; Pezzolesi MG; Waite KA; Eng C
Am J Hum Genet; 2007 Oct; 81(4):756-67. PubMed ID: 17847000
[TBL] [Abstract][Full Text] [Related]
31. Utilizing PTEN immunohistochemistry as a screening test for Cowden syndrome.
Hartsough E; DeSimone MS; Lorenzo ME; Dias-Santagata D; Nose V; Hoang MP
Am J Clin Pathol; 2024 May; 161(5):490-500. PubMed ID: 38206110
[TBL] [Abstract][Full Text] [Related]
32. PTEN: one gene, many syndromes.
Eng C
Hum Mutat; 2003 Sep; 22(3):183-98. PubMed ID: 12938083
[TBL] [Abstract][Full Text] [Related]
33. Two distinct thyroid tumours in a patient with Cowden syndrome carrying both a 10q23 and a mitochondrial DNA germline deletion.
Pradella LM; Zuntini R; Magini P; Ceccarelli C; Neri I; Cerasoli S; Graziano C; Gasparre G; Turchetti D
J Med Genet; 2011 Nov; 48(11):779-82. PubMed ID: 21926107
[TBL] [Abstract][Full Text] [Related]
34. Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest.
Nizialek EA; Peterson C; Mester JL; Downes-Kelly E; Eng C
Hum Mol Genet; 2013 Jun; 22(12):2451-61. PubMed ID: 23446638
[TBL] [Abstract][Full Text] [Related]
35. Germline PTEN Mutation Analysis for PTEN Hamartoma Tumor Syndrome.
Ngeow J; Eng C
Methods Mol Biol; 2016; 1388():63-73. PubMed ID: 27033071
[TBL] [Abstract][Full Text] [Related]
36. WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition.
Lee YR; Yehia L; Kishikawa T; Ni Y; Leach B; Zhang J; Panch N; Liu J; Wei W; Eng C; Pandolfi PP
N Engl J Med; 2020 May; 382(22):2103-2116. PubMed ID: 32459922
[TBL] [Abstract][Full Text] [Related]
37. Lifetime cancer risks in individuals with germline PTEN mutations.
Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
[TBL] [Abstract][Full Text] [Related]
38. Cowden syndrome.
Gustafson S; Zbuk KM; Scacheri C; Eng C
Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
[TBL] [Abstract][Full Text] [Related]
39. Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53.
He X; Ni Y; Wang Y; Romigh T; Eng C
Hum Mol Genet; 2011 Jan; 20(1):80-9. PubMed ID: 20926450
[TBL] [Abstract][Full Text] [Related]
40. Second malignant neoplasms in patients with Cowden syndrome with underlying germline PTEN mutations.
Ngeow J; Stanuch K; Mester JL; Barnholtz-Sloan JS; Eng C
J Clin Oncol; 2014 Jun; 32(17):1818-24. PubMed ID: 24778394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
